Clinical Trials Browser

Phase 1/2 × INDUSTRY × Humoral Hypercalcemia Of Malignancy × Clear all

NCT04198480 2019-12-13

A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM

Phase 1/2 Unknown

Humoral Hypercalcemia Of Malignancy

NCT00060138 2013-05-15

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Phase 1/2 Completed

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain